Cargando…
Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
The genetic aetiology and the molecular mechanisms that characterize high‐risk neuroblastoma are still little understood. The majority of high‐risk neuroblastoma patients do not take advantage of current induction therapy. So far, one of the main reasons liable for cancer therapeutic failure is the...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171401/ https://www.ncbi.nlm.nih.gov/pubmed/32103589 http://dx.doi.org/10.1111/jcmm.15058 |